T 1592/11 vom 11.05.2015
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2015:T159211.20150511
- Datum der Entscheidung
- 11. Mai 2015
- Aktenzeichen
- T 1592/11
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 01272094.2
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- PEN-TYPE INJECTOR HAVING AN ELECTRONIC CONTROL UNIT
- Name des Antragstellers
- DCA Design International Limited
- Name des Einsprechenden
- Novo Nordisk A/S
- Kammer
- 3.2.02
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 53(c)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 115(2)European Patent Convention R 99(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 15(3)
- Schlagwörter
- Admissibility of appeal - (yes)
Admissibility of late-filed documents (yes); remittal (no)
Method of treatment by therapy (yes)
Support and clarity of disclaimer (no)
Added subject-matter (no) - auxiliary request XIIIii
Novelty (yes)
Novelty - auxiliary request XIIIii - Orientierungssatz
- -
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of:
- claims 1 and 2 of auxiliary request XIIIii filed during oral proceedings;
- pages 2, 2a and 3 to 5 of the adapted description filed during oral proceedings; and
- figures 1 to 3 and 3A of the patent as granted.